Conversant Healthcare Systems
601 Genome Way
Suite 1200
Huntsville, AL 35806
Science Philosophy
Recent advances in the fields of genomics and proteomics are providing new ways to derive more valuable data from human blood samples. Advances in informatics can now support the compilation and analysis of genetic and clinical data on an unprecedented scale. Applications using both genomic and proteomic discoveries and information technology advancements to interrogate biospecimens represent unparalleled opportunities for the discovery and development of new diagnostic, therapeutic, and preventive agents.
Conversant firmly believes that providing open access to well collected and annotated human cancer specimens will rapidly accelerate the development of diagnostic tests, prognostic indicators, and therapeutic cures for cancer and other human diseases.